SCIOSCIA, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 1.884
NA - Nord America 1.493
AS - Asia 480
SA - Sud America 7
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.872
Nazione #
US - Stati Uniti d'America 1.489
IE - Irlanda 838
SE - Svezia 389
CN - Cina 223
IT - Italia 222
SG - Singapore 169
UA - Ucraina 150
RO - Romania 58
DE - Germania 52
FI - Finlandia 50
IN - India 41
FR - Francia 31
CZ - Repubblica Ceca 29
GB - Regno Unito 22
TR - Turchia 19
RU - Federazione Russa 11
BE - Belgio 7
ES - Italia 7
JP - Giappone 5
MY - Malesia 5
NL - Olanda 5
TW - Taiwan 5
CA - Canada 4
IQ - Iraq 4
NZ - Nuova Zelanda 4
BR - Brasile 3
CO - Colombia 3
HR - Croazia 3
IR - Iran 3
AU - Australia 2
DK - Danimarca 2
KR - Corea 2
NO - Norvegia 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
RS - Serbia 1
TH - Thailandia 1
Totale 3.872
Città #
Dublin 838
Chandler 412
Nyköping 300
Singapore 126
Jacksonville 94
Ashburn 90
Princeton 74
Boardman 61
New York 61
Timisoara 56
Dearborn 49
Helsinki 41
Munich 37
Foggia 33
Los Angeles 32
Nanjing 31
Wilmington 31
Pune 27
Brno 25
Ann Arbor 23
Beijing 22
Bari 16
Des Moines 15
Guangzhou 14
Nanchang 14
Shanghai 13
Chengdu 11
Jiaxing 8
San Mateo 8
Shenyang 8
Washington 8
Wuhan 8
Brussels 7
Buffalo 7
Cutrofiano 7
Chicago 6
Jinan 6
Paris 6
Hebei 5
Noicattaro 5
Redwood City 5
San Jose 5
Seattle 5
Springfield 5
Tianjin 5
Auckland 4
Borås 4
Cagliari 4
Genoa 4
Hangzhou 4
Hanover 4
Mykolayiv 4
Ningbo 4
Norwalk 4
Orange 4
Rome 4
Rui'an 4
Sabadell 4
Stevenage 4
Woodbridge 4
Albuquerque 3
Catania 3
Council Bluffs 3
Feira de Santana 3
Frankfurt am Main 3
Houston 3
Kuala Lumpur 3
Kunming 3
London 3
Milan 3
Ruvo Di Puglia 3
Sammichele di Bari 3
Taipei 3
Arezzo 2
Bitonto 2
Bucharest 2
Calgary 2
Cerignola 2
Charlottetown 2
Ferrara di Monte Baldo 2
Fuzhou 2
Hilden 2
Hsinchu 2
Kemerovo 2
Manfredonia 2
Medellín 2
Mumbai 2
Naples 2
Orta di Atella 2
Oviedo 2
Pavia 2
Polignano a Mare 2
Prague 2
Sala Bolognese 2
Shenzhen 2
Taizhou 2
Taranto 2
Verona 2
Acquaviva Delle Fonti 1
Ambrogio 1
Totale 2.811
Nome #
Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma–COPD overlap syndrome phenotype 114
Emorragia alveolare diffusa (DAH): recidiva della granulomatosi di Wegener dopo un trattato inadeguato 110
Exhaled breath condensate and respiratory diseases 90
Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases 85
Assessment of Induced Sputum Cellularity in COPD Patients Belonging to Two Different Classes of Air Pollution Exposure 81
Looking for airways periostin in severe asthma: could it be useful for clustering T2-high endotype? 81
A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy 77
Effetti a lungo termine della terapia con omalizumab, in pazienti con asma severo persistente non controllato 76
Disturbo bipoplare tipo II: un caso di disassuefazione tabagica e reinserimento sociale 65
MicroRNA expression profile during different conditions of hypoxia 63
Is the Exhaled Breath Temperature Sensitive to Cigarette Smoking? 60
Physical activity as a new tool to evaluate the response to omalizumab and mepolizumab in severe asthmatic patients: A pilot study 59
Real Time PCR and Culture-Based Virus Isolation Test in Clinically Recovered Patients: Is the Subject Still Infectious for SARS-CoV2? 57
Surgical mask and n95 in healthcare workers of covid-19 departments: Clinical and social aspects 57
Clinical Factors Associated with a Shorter or Longer Course of Antibiotic Treatment in Patients with Exacerbations of Bronchiectasis: A Prospective Cohort Study 54
Tabagismo e malattie fumo-correlate 54
Exhaled breath temperature in NSCLC: Could be a new non invasive marker? 53
The Role of Transthoracic Ultrasound in the Study of Interstitial Lung Diseases: High-Resolution Computed Tomography Versus Ultrasound Patterns: Our Preliminary Experience 53
A case of severe allergic eosinophilic asthma with nasal polyposis in a patient affected by birt-hogg-dubé syndrome successfully treated with benralizumab 52
Surgical mask and n95 in healthcare workers of covid-19 departments: Clinical and social aspects 51
Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma 51
Molecular study of the lung microbiome in patients with non-cystic fibrosis bronchiectasis: the contribution of Pseudomonas aeruginosa infection to clinical outcomes 50
Transthoracic ultrasound sign in severe asthmatic patients: a lack of “gliding sign” mimic pneumothorax 50
Asma bronchiale 50
Assessing value of contrast-enhanced ultrasound vs. conventional transthoracic ultrasound in improving diagnostic yield of percutaneous needle biopsy of peripheral lung lesions 50
Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension 49
Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience 49
Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis 49
Physical activity as a new tool to evaluate the response to omalizumab and mepolizumab in severe asthmatic patients: A pilot study 47
Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients 47
Downregulation of exosomal let-7d and miR-16 in idiopathic pulmonary fibrosis 47
Severe uncontrolled asthma with bronchiectasis: A pilot study of an emerging phenotype that responds to mepolizumab 46
Impact of CT Scan Phenotypes in Clinical Manifestations, Management and Outcomes of Hospitalised Patients with COVID-19 46
Machine learning-based prediction of adherence to continuous positive airway pressure (CPAP) in obstructive sleep apnea (OSA) 46
A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy 46
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 46
null 45
Omalizumab as add-on therapy in a patient with severe asthma and OSA 45
Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe Asthma 45
Exhaled Breath Temperature Home Monitoring to Detect NSCLC Relapse: Results from a Pilot Study 45
Knowledge of telemedicine in a sleep clinic during the COVID-19 pandemic by a phone survey 44
Impact of CT Scan Phenotypes in Clinical Manifestations, Management and Outcomes of Hospitalised Patients With COVID-19 44
The Potential Role of Airways Periostin in the Clinical Practice of Patients Affected by Idiopathic Pulmonary Fibrosis 44
Looking for airways periostin in severe asthma: could it be useful for clustering T2-high endotype? 43
Chest Imaging in the Diagnosis and Management of Pulmonary Tuberculosis: The Complementary Role of Thoraci Ultrasound 43
Chylothorax found in a patient with COVID-19 43
Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach 42
Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience 42
Lung Ultrasound in the Diagnosis of COVID-19 Pneumonia: Not Always and Not Only What Is COVID-19 “Glitters” 41
Low sensitivity of admission lung us compared to chest ct for diagnosis of lung involvement in a cohort of 82 patients with covid-19 pneumonia 40
Association between physical activity and risk of hospitalisation in bronchiectasis 40
Chylothorax found in a patient with COVID-19 40
Different Expression of Micro-RNA in the Subcutaneous and Visceral Adipose Tissue of Obese Subjects 39
The Role of Airways 17β-Estradiol as a Biomarker of Severity in Postmenopausal Asthma: A Pilot Study 39
How Are We Handling the Post-COVID Patients? The Dance of Uncertainties 39
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 39
Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone 38
Usefulness of sleep events detection using a wrist worn peripheral arterial tone signal device (WatchPAT™) in a population at low risk of obstructive sleep apnea 38
COVID-19 Pneumonia: The Great Ultrasonography Mimicker 38
Clinical Features of SARS-COV-2 Infection After Full Vaccination in Health Care Workers of a COVID Hospital 37
Effect of Hypoxia-Induced Micro-RNAs Expression on Oncogenesis 37
Obstructive Sleep Apnoea-Hypopnoea Syndrome (OSAHS): state of the art 37
Exhaled Breath Temperature Home Monitoring to Detect NSCLC Relapse: Results from a Pilot Study 36
The Potential Role of Airways Periostin in the Clinical Practice of Patients Affected by Idiopathic Pulmonary Fibrosis 35
Transthoracic ultrasound shear wave elastography for the study of subpleural lung lesions 35
Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach 34
Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases 34
Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management 34
Real-world experience with dupilumab in severe asthma: One-year data from an italian named patient program 34
Transthoracic Ultrasound in Infectious Organizing Pneumonia: A Useful Guide for Percutaneous Needle Biopsy 33
Survival of patients with idiopathic pulmonary fibrosis and pulmonary hypertension under therapy with nintedanib or pirfenidone 33
Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience 32
Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients 31
Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients 31
Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management 30
Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations 30
Effectiveness of benralizumab in severe eosinophilic asthma: Distinct sub-phenotypes of response identified by cluster analysis 30
Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe Asthma 30
Imaging profile after treatment with Tocilizumab in COVID-19: a case series 29
Could transthoracic ultrasound be useful to suggest a small airways disease in severe uncontrolled asthma? 29
Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations 28
Usefulness of sleep events detection using a wrist worn peripheral arterial tone signal device (WatchPAT™) in a population at low risk of obstructive sleep apnea 27
Switching from omalizumab to mepolizumab: real-life experience from Southern Italy 26
Efficacy of prone positioning in COVID-19 pneumonia according to radiological phenotypes 26
Tocilizumab and liver injury in patients with COVID-19 25
Therapeutic effects of benralizumab assessed in patients with severe eosinophilic asthma: Real-life evaluation correlated with allergic and non-allergic phenotype expression 21
Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis 19
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 18
Severe asthma: One disease and multiple definitions 17
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial 16
Soluble P-selectin in acute exacerbations and stable bronchiectasis in adults 15
Clinical Remission in Patients Affected by Severe Eosinophilic Asthma on Dupilumab Therapy: A Long-Term Real-Life Study 13
Mucoid Pseudomonas aeruginosa alters sputum viscoelasticity in patients with non-cystic fibrosis bronchiectasis 13
The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study 11
Controlling Nutritional Status Score as a Predictor for Chronic Obstructive Pulmonary Disease Exacerbation Risk in Elderly Patients 10
Intermittent Hypoxia Mediates Cancer Development and Progression Through HIF-1 and miRNA Regulation 10
EVs-miRNA: The New Molecular Markers for Chronic Respiratory Diseases 9
Searching for airways biomarkers useful to identify progressive pulmonary fibrosis 9
MiRNA and Exosomal miRNA as New Biomarkers Useful to Phenotyping Severe Asthma 8
Adaptive immunity in different CT patterns of active tuberculosis and possible variability according to patients' geographic provenience 7
Totale 4.136
Categoria #
all - tutte 33.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020279 0 0 0 0 26 34 35 2 26 15 30 111
2020/2021250 32 2 27 3 27 4 31 23 55 31 2 13
2021/2022402 25 1 4 7 45 6 23 22 58 88 4 119
2022/20232.093 159 99 107 89 126 215 11 184 989 15 41 58
2023/2024525 80 18 20 13 36 116 36 33 12 12 5 144
2024/2025365 111 41 93 67 53 0 0 0 0 0 0 0
Totale 4.216